Kristen Sanfilippo/X
Jun 22, 2025, 12:53
Kristen Sanfilippo: Time to Anticoagulants Therapy is a Modifiable Risk Factor for PE-associated Mortality
Kristen Sanfilippo, Hematologist in the Division of Hematology at Washington University School of Medicine, shared a post on X:
“Time to Anticoagulants therapy is a modifiable risk factor for PE-associated mortality.
- Big weekend for Kelsey Bria
- Finished Residency
- Started Fellowship as our newest ASH HFFTP
- First Oral “
More posts from ISTH 2025 on Hemostasis Today.
-
Mar 1, 2026, 05:44Ilenia Calcaterra: Innovation In Rare Diseases Is Never Abstract
-
Feb 28, 2026, 17:03Investing in Education, Prevention, and Lifesaving Research for a Healthier Tomorrow – AHA
-
Feb 28, 2026, 17:00Pamela Gavin: 1 in 10 Americans Live With A Rare Disease – That Is Not Rare, That Is Public Health
-
Feb 28, 2026, 16:59Thomas Rocco Jr: Exploring Agentic AI in Cardiovascular Medicine
-
Feb 28, 2026, 16:50Rob Maloney: Normalcy Is Not A Small Thing In Rare Disease
-
Feb 28, 2026, 16:49Céline Chapelle: Evaluating 6-Month Risks of Recurrent VTE and Major Bleeding With Tinzaparin
-
Feb 28, 2026, 16:46Nicolas Hulscher: Nattokinase Dissolves 84% of Amyloid Microclots In Vitro
-
Feb 28, 2026, 16:46Alfonso Tafur: Preventing Post-Hospitalization Blood Clots Using Precision Tools and Systems
-
Feb 28, 2026, 16:39Anel Karisik: Do Antidepressants Influence Swallowing Recovery After Acute Ischemic Stroke?